Search

Prof Dr Angela Brand, MD PhD MPH
Lehrstuhl und Direktor des Instituts für Klinische Chemie

Faculty of Health, Medicine and Life Sciences at Maastricht University
The Netherlands
www.maastrichtuniversity.nl

Founding Director and Full Professor of the Institute for Public Health Genomics (IPHG) at the Faculty of Health, Medicine and Life Sciences at Maastricht University, the Netherlands.

Dr. T.M.Pai Endowed Chair on Public Health Genomics and Adjunct Professor at the Manipal Life Sciences Centre of Manipal University, India.

https://www.maastrichtuniversity.nl/web/Profiel/a.brand.htm

Prof. Angela Brand, MD PhD MPH is Founder and Full Professor of the Institute for Public Health Genomics (IPHG) at the Faculty of Health, Medicine and Life Sciences at Maastricht University, the Netherlands, as well as Adjunct Professor at the Manipal Life Sciences Centre of Manipal University, India. She is Paediatrician and Specialist in Public Health Medicine, holds a PhD in pathology (Münster University, Germany) and a Master of Public Health from Johns Hopkins University, USA.

She received her habilitation in Public Health Genomics focussing on Health Technology Assessment (Bremen University, Germany) being in Europe the first HTA on genomics. She is Director of the European Centre for Public Health Genomics (ECPHG), which has a formal collaboration agreement with the EC-JRC IPTS in Sevilla and collaborates with Public Health Genomics related institutions and organizations all over the world such as the CDC Atlanta, the Public Health Agency Canada or the BGI China. She is Coordinator of the Public Health Genomics European Network (PHGEN, www.phgen.eu), Full Partner of the EU Flagship Project IT Future of Medicine (ITFoM, www.itfom.eu), President of the Section Public Health Genomics within the European Public Health Association (EUPHA), Edtor-in-Chief of the international journal Public Health Genomics, Excecutive Director of the Public Health Genomics international network GRaPH-Int, Associated Member of the international consortium Public Population Project in Genomics (P3G) on biobanking, Advisory Board Member of the EU Innovation Medicine Initiative (IMI) project OncoTrack (www.oncotrack.eu), Steering Committee Member of the “Forward Look on Personalized Medicine” of the European Science Foundation, and Scientific Consultation Group Member of the European Centre for Disease Prevention and Control (ECDC).

She serves as Expert for the European Agency for Reconstruction, the OECD, WHO, the European Commission, the Netherlands Genomics Initiative (NGI), the German Robert Koch-Institut (RKI), Genome Canada, the European Science Foundation  among others. She collaborates for several years also with industry partners mainly in the field of Pharmacogenomics such as with Roche, Pfizer, Novartis, MSD or Bayer-Schering and produced for them also HTA reports on health innovations. She is Fellow of the Rockefeller Foundation, USA, and of the 21st Century Trust of the Wellcome Trust, UK.